The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity

Free Radical Biology and Medicine

Volumn 37, Issue 12, 2004, Pages 1986-1994

  James, Richard W ^a   Deakin, Sara P ^a  

^a Secretariat   (Switzerland)

Author keywords

Free radicals

Indexed keywords

ARYLDIALKYLPHOSPHATASE; HIGH DENSITY LIPOPROTEIN;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; ELECTRON MICROSCOPY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME METABOLISM; ENZYME POLYMORPHISM; ENZYME RELEASE; ENZYME STABILITY; LIPID COMPOSITION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN LIPID INTERACTION; PROTEIN SECRETION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW;

ANIMALS; ARYLDIALKYLPHOSPHATASE; ENZYME STABILITY; HUMANS; LIPOPROTEINS, HDL; PROTEIN BINDING;

EID: 8544270882     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2004.08.012     Document Type: Review

References (57)

1. V.W. Bowry, K.K. Stanley, and R. Stocker High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors Proc. Natl. Acad. Sci. USA 89 1992 10316 10320
2. A.R. Tall Plasma high density lipoproteins: metabolism and relationship to atherogenesis J. Clin. Invest. 86 1990 379 384
3. I. Staprans, X.-M. Pan, J.H. Rapp, and K.R. Feingold Oxidized cholesterol in the diet is a source of oxidized lipoproteins in human serum J. Lipid Res. 44 2003 705 715
4. M.-C. Blatter Garin, C. Abbot, S. Messmer, M.I. Mackness, P. Durrington, D. Pometta, and R.W. James Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations Biochem. J. 304 1994 549 554
5. R. Humbert, D.A. Adler, C.M. Disteche, C. Hassett, C.J. Omiecinski, and C.E. Furlong The molecular basis of the human serum paraoxonase activity polymorphism Nat. Genet. 3 1993 73 76
6. S. Adkins, K.N. Gan, M. Mody, and B.N. La Du Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes Am. J. Hum. Genet. 52 1993 598 608
7. I. Leviev, and R.W. James Promoter polymorphisms of the human paraoxonase PON1 gene and serum paraoxonase activities and concentrations Arterioscler. Thromb. Vasc. Biol. 20 2000 516 521
8. T. Suehiro, T. Nakamura, M. Inoue, T. Shiinoki, Y. Ikeda, Y. Kumon, M. Shindo, H. Tanaka, and K. Hashimoto A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression Atherosclerosis 150 2000 295 298
9. V.H. Brophy, M.D. Hastings, J.B. Clendenning, R.J. Richter, G.P. Jarvik, and C.E. Furlong Polymorphisms in the human paraoxonase (PON1) promoter Pharmacogenetics 11 2001 77 84
10. H.G. Davis, R.J. Richter, M. Keifer, C.A. Broomfield, J. Sowalla, and C.E. Furlong The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin Nat. Genet. 14 1996 334 336
11. S. Deakin, I. Leviev, M.C. Brulhart Meynet, and R.W. James Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role in vivo for polymorphic position -107 implicating the transcription factor Sp1 Biochem. J. 372 2003 643 649
12. V.H. Brophy, R.L. Jampsa, J.B. Clendenning, L.A. McKinstry, G.P. Jarvik, and C.E. Furlong Effects of 5′ regulatory-region polymorphisms on paraoxonase-gene (PON1) expression Am. J. Hum. Genet. 68 2001 1428 1436
13. S. Deakin, I. Leviev, S. Guernier, and R.W. James Simvastatin modulates expression of the PON1 gene and increases serum paraoxonase: a role for sterol regulatory element-binding protein-2 Arterioscler. Thromb. Vasc. Biol. 23 2003 2083 2089
14. K.R. Feingold, R.A. Memon, A.H. Moser, and C. Grunfeld Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response Atherosclerosis 139 1998 307 315
15. B.J. Van Lenten, A.C. Wagner, D.P. Nayak, S. Hama, M. Navab, and A.M. Fogelman High-density lipoprotein loses its anti-inflammatory properties during acute influenza A infection Circulation 103 2001 2283 2288
16. V.G. Cabana, C.A. Reardon, N. Feng, S. Neath, J. Lukens, and G.S. Getz Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response J. Lipid Res. 44 2003 780 792
17. B. Martoglio, and B. Dobberstein Signal sequences: more than just greasy peptides Trends Cell Biol. 8 1998 41041 41045
18. R.C. Sorenson, C.L. Bisgaier, M. Aviram, C. Hsu, S. Billecke, and B.N. La Du Human serum paraoxonase/arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids: apolipoprotein A-I stabilizes activity Arterioscler. Thromb. Vasc. Biol. 19 1999 2214 2225
19. C. Hassett, R.J. Richter, R. Humbert, C. Chapline, J.W. Crabb, C.J. Omiecinski, and C. Furlong Characterisation of cDNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequence Biochemistry 30 1991 10141 10149
20. S.T. Reddy, D.J. Wadleigh, V. Grijalva, C. Ng, S. Hama, A. Gangopadhyay, D.M. Shih, A.J. Lusis, M. Navab, and A.M. Fogelman Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids Arterioscler. Thromb. Vasc. Biol. 21 2001 542 547
21. C.J. Ng, D.J. Wadleigh, A. Gangopadhyay, S. Hama, V.R. Grijalva, M. Navab, A.M. Fogelman, and S.T. Reddy Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein J. Biol. Chem. 276 2001 44444 44449
22. S. Deakin, I. Leviev, M. Gomaraschi, L. Calabresi, G. Franceschini, and R.W. James Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism J. Biol. Chem. 277 2002 4301 4308
23. L. Kall, A. Krogh, and E.L. Sonnhammer A combined transmembrane topology and signal peptide prediction method J. Mol. Biol. 338 2004 1027 1036
24. M.N. Oda, J.K. Bielicki, T. Berger, and T.M. Forte Cysteine substitutions in apolipoprotein A-I primary structure modulate paraoxonase activity Biochemistry 40 2001 1710 1718
25. S. Acton, A. Rigotti, K.T. Landschulz, S. Xu, H.H. Hobbs, and M. Krieger Identification of scavenger receptor SR-BI as a high density lipoprotein receptor Science 271 1996 518 520
26. M. Krieger Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI Annu. Rev. Biochem. 68 1999 523 558
27. M.I. Mackness, C.H. Walker, and L.A. Carlson Low A-esterase activity in serum of patients with fish-eye disease Clin. Chem. 33 1987 587 588
28. R.W. James, M.C. Blatter Garin, L. Calabresi, R. Miccoli, A. von Eckardstein, M. Tilly-Kiesi, M.-R. Taskinen, G. Assmann, and G. Franceschini Modulated serum activities and concentrations of paraoxonase in high density lipoprotein deficiency states Atherosclerosis 139 1998 77 82
29. M.I. Mackness, and C.H. Walker Multiple forms of sheep serum A-esterase activity associated with the high-density lipoprotein Biochem. J. 250 1988 539 545
30. R. Zech, M. Rockseisen, K. Kluge, K. Dewald, V.W. Armstrong, and J.M. Chemnitius Lipoproteins and hydrolysis of organophosphorus compounds Chem. Biol. Interact. 87 1993 85 94
31. M.-C. Blatter, R.W. James, S. Messmer, F. Barja, and D. Pometta Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45: identity of K-45 with paraoxonase Eur. J. Biochem. 211 1993 871 879
32. G.J. Kelso, W.D. Stuart, R.J. Richter, C.E. Furlong, T.C. Jordan-Starck, and J.A.K. Harmony Apolipoprotein J is associated with paraoxonase in human plasma Biochemistry 33 1994 832 839
33. K.A. Rye, M.A. Clay, and P.J. Barter Remodelling of high density lipoproteins by plasma factors Atherosclerosis 145 1999 227 238
34. A. Kontush, S. Chantepie, and M.J. Chapman Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress Arterioscler. Thromb. Vasc. Biol. 23 2003 1881 1888
35. J. Valabhji, A.J. McColl, M. Schachter, S. Dhanjil, W. Richmond, and R.S. Elkeles High-density lipoprotein composition and paraoxonase activity in Type I diabetes Clin. Sci. 101 2001 659 670
36. S.T. Kunitake, and J.P. Kane Factors affecting the integrity of high density lipoproteins in the ultracentrifuge J. Lipid Res. 23 1982 936 940
37. James R.W., Hochstrasser D., Tissot J.-D., Funk M., Appel R., Barja F., Pellegrini C., Muller A.F., Pometta D., Protein heterogeneity of lipoprotein particles containing apolipoprotein A-I without apolipoprotein A-II and apolipoprotein A-I with apolipoprotein A-II, isolated from human plasma. J. Lipid Res. 29 1557-1571; 1988
38. P. Alaupovic The concept of apolipoprotein-defined lipoprotein families and its clinical significance Curr. Atheroscler. Rep. 5 2003 459 567
39. M.R. Wilson, and S.B. Easterbrook-Smith Clusterin is a secreted mammalian chaperone Trends Biochem. Sci. 25 2000 95 98
40. S.E. Jones, and C. Jomary Clusterin Int. J. Biochem. Cell. Biol. 34 2002 427 431
41. M. Navab, S. Hama-Levy, B. Van Lenten, G.C. Fonarow, C.J. Cardinez, L.W. Castellani, M.-L. Brennan, A.J. Lusus, and A.M. Fogelman Mildly oxidised LDL induces an increased apolipoprotein J/paraoxonase ratio J. Clin. Invest. 99 1997 2005 2019
42. N. Xu, and B. Dahlback A novel human apolipoprotein (apoM) J. Biol. Chem. 274 1999 31286 31290
43. A.B. Smith, J.D. Esko, and S.L. Hajduk Killing of trypanosomes by the human haptoglobin-related protein Science 268 1995 284 286
44. M. Harel, A. Aharoni, L. Gaidukov, B. Brumshtein, O. Khersonsky, R. Meged, H. Dvir, R.B. Ravelli, A. McCarthy, L. Toker, I. Silman, J.L. Sussman, and D.S. Tawfik Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes Nat. Struct. Mol. Biol. 11 2004 412 419
45. C. Bruce, W.S. Davidson, P. Kussie, S. Lund-Katz, M.C. Phillips, R. Ghosh, and A.R. Tall Molecular determinants of plasma cholesteryl ester transfer protein binding to high density lipoproteins J. Biol. Chem. 270 1995 11532 11542
46. L.W. Castellani, M. Navab, B.J. Van Lenten, C.C. Hendrick, S.Y. Hama, A.M. Goto, A.M. Fogelman, and A.J. Lusis Overexpression of apolipoprotein A-II in transgenic mice converts high density lipoproteins to pro-inflammatory particles J. Clin. Invest. 100 1997 464 474
47. E. Boisfer, D. Stengel, D. Pastier, P.M. Laplaud, N. Dousset, E. Ninio, and A.D. Kalopissis Antioxidant properties of HDL in transgenic mice overexpressing human apolipoprotein A-II J. Lipid Res. 43 2002 732 741
48. M.I. Mackness, P.N. Durrington, and B. Mackness How high-density lipoprotein protects against the effects of lipid peroxidation Curr. Opin. Lipidol. 11 2000 383 388
49. G. Camejo, E. Hurt-Camejo, O. Wiklund, and G. Bondjers Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis Atherosclerosis 139 1998 205 222
50. M. Navab, S.Y. Hama, G.P. Hough, C.C. Hedrick, R. Sorenson, B.N. La Du, J.A. Kobashigawa, G.C. Fonarow, J.A. Berliner, H. Laks, and A.M. Fogelman High density associated enzymes: their role in vascular biology Curr. Opin. Lipidol. 9 1998 449 456
51. J.K. Christison, K.A. Rye, and R. Stocker Exchange of oxidized cholesteryl linoleate between LDL and HDL mediated by cholesteryl ester transfer protein J. Lipid Res. 36 1995 2017 2026
52. M. Navab, G.M. Ananthramaiah, S.T. Reddy, B.J. Van Lenten, B.J. Ansell, G.C. Fonarow, K. Vahabzadeh, S. Hama, G. Hough, N. Kamranpour, J.A. Berliner, A.J. Lusis, and A.M. Fogelman The pathogenesis of atherosclerosis: the oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL J. Lipid Res. 45 2004 993 1007
53. B. Mackness, R. Hunt, P.N. Durrington, and M.I. Mackness Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis Arterioscler. Thromb. Vasc. Biol. 17 1997 1233 1238
54. M. Aviram, E. Hardak, J. Vaya, S. Mahmood, S. Milo, A. Hoffman, S. Billicke, D. Draganov, and M. Rosenblat Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities Circulation 101 2000 2510 2517
55. C.M. Uhlar, and A.S. Whitehead Serum amyloid A, the major vertebrate acute phase protein Eur. J. Biochem. 265 1999 501 523
56. J.R. Nofer, B. Kehrel, M. Fobker, B. Levkau, G. Assmann, and A. von Eckardstein HDL and arteriosclerosis: beyond reverse cholesterol transport Atherosclerosis 161 2002 1 16
57. Z. Ahmed, A. Ravandi, G.F. Maguire, A. Emili, D. Draganov, B.N. La Du, A. Kuksis, and P.W. Connelly Apolipoprotein A-I promotes the formation of phosphatidylcholine core aldehydes that are hydrolyzed by paraoxonase (PON-1) during high density lipoprotein oxidation with a peroxynitrite donor J. Biol. Chem. 276 2001 24473 24481